Reducing third-generation cephalosporin use among inpatients can effectively decrease the occurrence of Clostridium difficile-associated diarrhoea

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1374, 2003-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibacterials: Clostridium difficile-associated diarrhoea (first report with azithromycin and secnidazole): 6 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1194-1195, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Loperamide: Worsening of Clostridium difficile-associated diarrhoea and toxic megacolon in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1162, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

C. difficile-associated diarrhoea imposes high cost burden in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 358, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Clostridium difficile-Associated Disease: Changing Epidemiology and Implications for Management

By Owens Robert C.  

Drugs, Vol. 67, Iss. 4, 2007-01 ,pp. : 487-502

Adis International

Access to resources Recommend Favorite

Fidaxomicin for treatment of clostridium difficile-associated diarrhea and its potential role for prophylaxis

By Hostler Christopher J  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 11, 2013-08 ,pp. : 1529-1536

Informa Healthcare

Access to resources Recommend Favorite